[GlobeNewswire] – CAMBRIDGE, Mass. — Cerulean Pharma Inc. today announced that the underwriters for its initial public offering of common stock have exercised their over-allotment option and purchased an additional 1,069,715 … moreView todays social media effects on CERUView the latest stocks trending across Twitter. Click to view dashboardSee who Cerulean is hiring next, click here to view […]
moreView todays social media effects on CERUView the latest stocks trending across Twitter. Click to view dashboardSee who Cerulean is hiring next, click here to view […]
Welcome to our daily roundup of top insider trades. Here’s a look at the most significant inside purchases recently filed with the SEC.Notable Purchases:
The billionaire activist investor Carl Icahn, a beneficial owner of commercial and military truck company Navistar International (NYSE:NAV), bought 1,027,789 shares of company stock for $34,205,404.
The venture capital firm Polaris Venture Management bought 1,470,582 shares of clinical-stage oncology-focused company Cerulean Pharmaceuticals (NASDAQ:CERU) […]
